Total Payments
$599.16
2024 Payments
$62.50
Companies
8
Transactions
27
Medicare Patients
1,975
Medicare Billing
$369,330
Payment Breakdown by Category
Food & Beverage$599.16 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $599.16 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $302.88 | 14 | $0 (2020) |
| TETRAPHASE PHARMACEUTICALS, INC. | $86.35 | 4 | $0 (2020) |
| Ethicon US, LLC | $62.50 | 1 | $0 (2024) |
| Insmed, Inc. | $54.48 | 3 | $0 (2020) |
| Shire North American Group Inc | $36.86 | 2 | $0 (2018) |
| AbbVie Inc. | $27.67 | 1 | $0 (2023) |
| Tactile Systems Technology Inc | $15.68 | 1 | $0 (2019) |
| Cumberland Pharmaceuticals, Inc. | $12.74 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62.50 | 1 | Ethicon US, LLC ($62.50) |
| 2023 | $27.67 | 1 | AbbVie Inc. ($27.67) |
| 2020 | $280.73 | 11 | Allergan, Inc. ($224.41) |
| 2019 | $151.21 | 9 | TETRAPHASE PHARMACEUTICALS, INC. ($66.09) |
| 2018 | $77.05 | 5 | Allergan Inc. ($40.19) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Ethicon US, LLC | Echelon; Endopath (Device) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Endo-Mechanical | ||||||
| 12/21/2023 | AbbVie Inc. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/09/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/09/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/28/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/24/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/02/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/24/2020 | Cumberland Pharmaceuticals, Inc. | Vibativ (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/08/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Respiratory | ||||||
| 02/13/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/12/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/16/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $125.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/08/2020 | TETRAPHASE PHARMACEUTICALS, INC. | XERAVA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 12/18/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/13/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 11/06/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Respiratory | ||||||
| 10/16/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/04/2019 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 08/21/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Respiratory | ||||||
| 08/07/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 06/05/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/13/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 12/19/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/13/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/31/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 429 | 1,039 | $351,344 | $88,884 |
| 2022 | 3 | 192 | 471 | $103,300 | $30,820 |
| 2021 | 2 | 590 | 1,640 | $361,666 | $106,165 |
| 2020 | 5 | 764 | 2,161 | $494,100 | $143,462 |
Total Patients
1,975
Total Services
5,311
Medicare Billing
$369,330
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 135 | 474 | $168,724 | $42,576 | 25.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 151 | 172 | $88,462 | $22,558 | 25.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 127 | 376 | $87,570 | $22,055 | 25.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 17 | $6,588 | $1,695 | 25.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 105 | 381 | $76,200 | $20,715 | 27.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 72 | 75 | $20,650 | $7,761 | 37.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $6,450 | $2,344 | 36.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 314 | 1,324 | $274,900 | $73,285 | 26.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 276 | 316 | $86,766 | $32,880 | 37.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 380 | 1,695 | $381,375 | $97,383 | 25.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 315 | 358 | $98,450 | $38,957 | 39.6% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2020 | 26 | 41 | $7,175 | $3,663 | 51.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 51 | $5,100 | $2,958 | 58.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 16 | $2,000 | $501.50 | 25.1% |
About Dr. Farheen Tariq, M.D
Dr. Farheen Tariq, M.D is a Infectious Disease healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083674485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Farheen Tariq, M.D has received a total of $599.16 in payments from pharmaceutical and medical device companies, with $62.50 received in 2024. These payments were reported across 27 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($599.16).
As a Medicare-enrolled provider, Tariq has provided services to 1,975 Medicare beneficiaries, totaling 5,311 services with total Medicare billing of $369,330. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Sugar Land, TX
- Active Since 03/28/2006
- Last Updated 01/27/2026
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1083674485
Products in Payments
- DALVANCE (Drug) $184.03
- AVYCAZ (Drug) $146.52
- Xerava (Drug) $66.09
- Echelon; Endopath (Device) $62.50
- Arikayce (Drug) $54.48
- GATTEX (Drug) $36.86
- XERAVA (Drug) $20.26
- FLEXITOUCH (Device) $15.68
- Vibativ (Drug) $12.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Sugar Land
Irene Ekaney, Md, MD
Infectious Disease — Payments: $21,310
Infectious Disease $21,310
John Butler, Md, MD
Infectious Disease — Payments: $19,539
Infectious Disease $19,539
Obiageli Obijiofor, Md, MD
Infectious Disease — Payments: $10,941
Infectious Disease $10,941
Dr. Sushma Singh, Mbbs, MBBS
Infectious Disease — Payments: $2,562
Infectious Disease $2,562
Ambreen Allana, Md, MD
Infectious Disease — Payments: $460.87
Infectious Disease $460.87
Anh Nguyen, Md, MD
Infectious Disease — Payments: $209.02
Infectious Disease $209.02